Cepheid Launches Multiplex Vaginal Panel (MVP) to Support More Accurate Women's Health Diagnosis in U.S.

FDA-cleared PCR test aids in the faster identification of three distinct conditions within an hour
SUNNYVALE, Calif., Nov. 15, 2022 /PRNewswire/ -- Cepheid announced today that it has launched Xpert... | November 15, 2022

Related Keywords

Darwa Peterson ,David Persing ,Centers For Disease ,Cepheid ,Danaher Corporation ,Xpert Xpress ,Chief Scientific ,Van Der Pol ,Vaginal Panel Assay Compared With ,Clinical Diagnosis ,Disease Control ,Antimicrobial Resistance ,Recurrent Bacterial Vaginosis ,Current Recommendations ,Cepheid Media Inquiries ,Danaher Corporation Stock Exchange ,News ,Information ,Press Release ,Cr ,Pest ,Kids ,N ,The ,Easter ,Identification ,F ,Three ,Distinct ,Conditions ,Ithin ,022 ,Nnounced ,Oday ,Hat ,It ,Gas ,Aunched Dhr Us2358511028 ,